tradingkey.logo
搜索

BCPE Perseus Investor Ord Shs (Proposed)

KLRA
添加自选
11.890USD
-1.240-9.44%
交易中 09/24, 11:15美东
1.54B总市值
0.00市盈率 TTM

BCPE Perseus Investor Ord Shs (Proposed)

11.890
-1.240-9.44%

关于 BCPE Perseus Investor Ord Shs (Proposed) 公司

Kailera Therapeutics Inc is a United States-based company. The Company is a clinical-stage biopharmaceutical company developing a broad and advanced therapeutic pipeline that is poised to deliver differentiated treatment options for obesity and related conditions. Its pipeline consists of clinical- and preclinical-stage programs with injectable peptides, oral peptides, and an oral small molecule.

BCPE Perseus Investor Ord Shs (Proposed) 简介

公司代码KLRA
公司名称Kailera Therapeutics Inc
上市日期Apr 17, 2026
CEORenaud (Ron)
员工数量- -
证券类型Ordinary Share
年结日- -
公司地址180 Third Ave
城市WALTHAM
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编02451
电话15084409475
网址https://www.kailera.com
公司代码KLRA
上市日期Apr 17, 2026
CEORenaud (Ron)

BCPE Perseus Investor Ord Shs (Proposed)公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Ronald C. (Ron) Renaud, Jr.
Mr. Ronald C. (Ron) Renaud, Jr.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Paul Burgess, J.D.
Mr. Paul Burgess, J.D.
Chief Operating Officer, Chief Business Officer
Chief Operating Officer, Chief Business Officer
--
--
Ms. Paula Cloghessy
Ms. Paula Cloghessy
Chief People Officer
Chief People Officer
--
--
Mr. Scott M. Akamine, J.D.
Mr. Scott M. Akamine, J.D.
Chief Legal Officer, Secretary
Chief Legal Officer, Secretary
--
--
Ms. Jamie Coleman
Ms. Jamie Coleman
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Douglas W. Pagan
Mr. Douglas W. Pagan
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Scott Wasserman, M.D.
Dr. Scott Wasserman, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Dr. John F. Milligan, Ph.D.
Dr. John F. Milligan, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Franklin K. (Frank) Clyburn, Jr.
Mr. Franklin K. (Frank) Clyburn, Jr.
Independent Director
Independent Director
--
--
Mr. Christopher D. (Chris) Hite, J.D.
Mr. Christopher D. (Chris) Hite, J.D.
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Ronald C. (Ron) Renaud, Jr.
Mr. Ronald C. (Ron) Renaud, Jr.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Paul Burgess, J.D.
Mr. Paul Burgess, J.D.
Chief Operating Officer, Chief Business Officer
Chief Operating Officer, Chief Business Officer
--
--
Ms. Paula Cloghessy
Ms. Paula Cloghessy
Chief People Officer
Chief People Officer
--
--
Mr. Scott M. Akamine, J.D.
Mr. Scott M. Akamine, J.D.
Chief Legal Officer, Secretary
Chief Legal Officer, Secretary
--
--
Ms. Jamie Coleman
Ms. Jamie Coleman
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Douglas W. Pagan
Mr. Douglas W. Pagan
Chief Financial Officer
Chief Financial Officer
--
--

常见问题

BCPE Perseus Investor Ord Shs (Proposed)的前五大股东是谁?

BCPE Perseus Investor Ord Shs (Proposed) 的前五大股东如下:Mr. Ronald C. (Ron) Renaud, Jr.
tradingkey.logo
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有